| ICD10 Disease Category |
Disease Name |
ICD10 Code |
Linked Targets |
| E00-E89: Endocrine, nutritional and metabolic diseases |
Hyperlipidaemia |
E78 |
HMGCR; HCAR2 |
| C00-D49: Neoplasms |
Multiple myeloma |
C90 |
HMGCR |
| A00-B99: Certain infectious and parasitic diseases |
HBV infection |
B16, B18.0, B18.1 |
HMGCR |
| E00-E89: Endocrine, nutritional and metabolic diseases |
Type 2 diabetes |
E11 |
HCAR2 |
| NA: NA |
Dyslipidemia |
NA |
HMGCR |
| M00-M99: Diseases of the musculoskeletal system and connective tissue |
Rheumatoid arthritis |
M05-M06 |
CNR2 |
| NA: NA |
Hyperlipidemia |
NA |
HMGCR |
| I00-I99: Diseases of the circulatory system |
Myocardial infarction |
I21, I22 |
HMGCR |
| I00-I99: Diseases of the circulatory system |
Thrombosis |
I80-I82 |
HMGCR |
| E00-E89: Endocrine, nutritional and metabolic diseases |
Dyslipidaemias |
E78 |
HMGCR |
| C00-D49: Neoplasms |
Thyroid cancer |
C73 |
TSHR |
| I00-I99: Diseases of the circulatory system |
Acute ischemic stroke |
I61-I63 |
HCAR2 |
| W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure |
Diagnostic test to differentiate primary and secondary hypothyroidism |
W88 |
TSHR |
| I00-I99: Diseases of the circulatory system |
Cerebrovascular ischaemia |
I61-I63 |
HMGCR |
| D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism |
Immune disorder |
D80-D89 |
CNR2 |
| K00-K95: Diseases of the digestive system |
Chemotherapy or radiotherapy-induced mucositis |
K12.3, R52, G89 |
HMGCR |
| L00-L99: Diseases of the skin and subcutaneous tissue |
Atopic dermatitis |
L00-L99 |
CNR2 |
| K00-K95: Diseases of the digestive system |
Inflammatory bowel disease |
K50, K51 |
CNR2 |
| C00-D49: Neoplasms |
Advanced breast cancer |
C50 |
CYP19A1 |
| F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Major depressive disorder |
F32, F33, M32 |
HCAR2 |
| I00-I99: Diseases of the circulatory system |
Cardiovascular disorder |
I00-I99 |
HMGCR; HCAR2 |
| F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Anxiety disorder |
F32, F40-F42 |
CYP3A4 |
| C00-D49: Neoplasms |
Bladder cancer |
C67 |
CYP19A1 |
| N00-N99: Diseases of the genitourinary system |
Prostate disease |
N42.9 |
CYP19A1 |
| C00-D49: Neoplasms |
Breast cancer |
C50 |
CYP19A1 |
| C00-D49: Neoplasms |
Thyroid cancer diagnosis |
C73 |
TSHR |
| G00-G99: Diseases of the nervous system G00-G99 |
Neuropathic pain |
G64, G90.0 |
CNR2 |
| C00-D49: Neoplasms |
Hormonally-responsive breast cancer |
C50 |
CYP19A1 |
| C00-D49: Neoplasms |
Inflammatory disease |
C11, C44, K75.9, M00-M25 |
CNR2 |
| I00-I99: Diseases of the circulatory system |
Arteriosclerosis |
I70 |
HMGCR; HCAR2 |
| I00-I99: Diseases of the circulatory system |
Atherosclerosis |
I70 |
HMGCR; HCAR2 |
| N00-N99: Diseases of the genitourinary system |
Endometriosis |
N80 |
CYP19A1 |
| NA: NA |
Cardiovascular disease |
NA |
HMGCR |
| M00-M99: Diseases of the musculoskeletal system and connective tissue |
Osteoporosis |
M80-M81, Z79.890 |
CNR2 |
| G00-G99: Diseases of the nervous system G00-G99 |
Pain |
G64, G90.0, R52, G89 |
CNR2 |
| E00-E89: Endocrine, nutritional and metabolic diseases |
Elevated CRP |
E78.0 |
HMGCR |
| E00-E89: Endocrine, nutritional and metabolic diseases |
Hypercholesterolemia |
E78 |
HMGCR |
